Register for streaming realtime charts, analysis tools, and prices.

Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 Next >>

Date	Time	Source	Headline	Symbol	Company
05/06/2019	5:13PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
05/06/2019	6:30AM	GlobeNewswire Inc.	Alector Announces First Alzheimer’s Disease Patient Dosed in Phase 1b Study of AL002	NYSE:ABBV	AbbVie Inc
05/03/2019	10:29AM	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:ABBV	AbbVie Inc
04/30/2019	2:57PM	Dow Jones News	FDA Approves AbbVie's Mavyret for All Genotypes of Hepatitis C in Pediatric Patients	NYSE:ABBV	AbbVie Inc
04/30/2019	1:49PM	Dow Jones News	AbbVie Gets European Commission Approval of Skyrizi in Plaque Psoriasis Treatment	NYSE:ABBV	AbbVie Inc
04/30/2019	7:45AM	PR Newswire (US)	European Commission Approves SKYRIZI™ (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis	NYSE:ABBV	AbbVie Inc
04/30/2019	7:08AM	PR Newswire (US)	AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson's Disease and Multiple Sclerosis at 2019 Am...	NYSE:ABBV	AbbVie Inc
04/25/2019	8:43AM	Dow Jones News	AbbVie Raises Adjusted Profit Guidance	NYSE:ABBV	AbbVie Inc
04/25/2019	7:46AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
04/25/2019	7:42AM	PR Newswire (US)	AbbVie Reports First-Quarter 2019 Financial Results	NYSE:ABBV	AbbVie Inc
04/23/2019	6:19PM	PR Newswire (US)	AbbVie Expands Immunology Portfolio in the U.S. with FDA Approval of SKYRIZI™ (risankizumab-rzaa) for Moderate to Severe Pl...	NYSE:ABBV	AbbVie Inc
04/23/2019	3:22PM	Dow Jones News	Trovagene Shares Rising Tuesday Following Preclinical Data Release	NYSE:ABBV	AbbVie Inc
04/18/2019	10:05AM	PR Newswire (Canada)	Health Canada Approves SKYRIZI™ (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis	NYSE:ABBV	AbbVie Inc
04/18/2019	10:05AM	PR Newswire (Canada)	Santé Canada approuve SKYRIZIMC (risankizumab) pour le traitement du psoriasis en plaques modéré à grave	NYSE:ABBV	AbbVie Inc
04/17/2019	1:48PM	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	NYSE:ABBV	AbbVie Inc
04/11/2019	9:00AM	PR Newswire (Canada)	MAVIRET(MC) d'AbbVie maintenant remboursé au Québec	NYSE:ABBV	AbbVie Inc
04/11/2019	9:00AM	PR Newswire (Canada)	AbbVie's MAVIRET™ now reimbursed in Quebec	NYSE:ABBV	AbbVie Inc
04/04/2019	10:00AM	PR Newswire (Canada)	AbbVie Announces New Formulary Listings for its Hepatitis C Treatment MAVIRET™	NYSE:ABBV	AbbVie Inc
04/03/2019	8:00AM	PR Newswire (US)	AbbVie to Host First-Quarter 2019 Earnings Conference Call	NYSE:ABBV	AbbVie Inc
04/02/2019	5:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/02/2019	5:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/02/2019	5:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/01/2019	4:30PM	GlobeNewswire Inc.	Alector Initiates Phase 1 Trial of AL003 for the Treatment of Patients with Alzheimer’s Disease	NYSE:ABBV	AbbVie Inc
04/01/2019	11:52AM	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	NYSE:ABBV	AbbVie Inc
03/29/2019	11:14AM	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	NYSE:ABBV	AbbVie Inc
03/26/2019	1:00AM	PR Newswire (US)	AbbVie Announces First Regulatory Approval of SKYRIZI™ (risankizumab) for the Treatment of Plaque Psoriasis, Generalized Pu...	NYSE:ABBV	AbbVie Inc
03/25/2019	4:36PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
03/22/2019	4:43PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NYSE:ABBV	AbbVie Inc
03/22/2019	10:29AM	PR Newswire (Canada)	British Columbia PharmaCare Lists AbbVie's Hepatitis C Treatment MAVIRET™ on its Formulary	NYSE:ABBV	AbbVie Inc
03/19/2019	8:45AM	PR Newswire (US)	AbbVie Provides Update on VENCLEXTA®/VENCLYXTO® (venetoclax) Multiple Myeloma Program	NYSE:ABBV	AbbVie Inc

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 Next >>

Ethema Health (PK)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Anavex Life Sciences

Fannie Mae (QB)

Intergrated Cannabis Sol... (PK)

Lightwave Logic

Kraig Biocraft Laborator... (QB)

Rennova Health (PK)

RespireRx Pharmaceuticals (PK)

Elite Pharmaceuticals (QB)

Net Savings Link (PK)

Delayed Upgrade Clock